ETFs with Arcellx, Inc. (ACLX)

Arcellx, Inc. is a company in the U.S. stock market and it is a holding in 35 U.S.-traded ETFs. ACLX has around 4.0M shares in the U.S. ETF market. The largest ETF holder of ACLX is the SPDR S&P Biotech ETF (XBI), with approximately 1.03M shares. Investors may also find of interest that the ETF with the largest allocation to ACLX stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 3.53%. On average, U.S. ETFs allocate 0.21% of ACLX to their portfolios.

Additionally, ACLX is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ACLX as a holding is the Invesco Nasdaq Biotechnology ETF (IBBQ), with a return of 5.69%.